栓塞性缺血性中风与维持静脉免疫球蛋白疗法相关
Ryoji Miyano1, Yu Yoshida1, Kazuki Fujita1
1Department of Neurology, Jichi Medical University, Saitama Medical Center, Japan.
Internal medicine (Tokyo, Japan)
|February 23, 2026
概括
针对慢性炎症性脱髓化多基原蛋白神经病 (CIDP) 进行静脉注射免疫球蛋白 (IVIG) 治疗,很少会导致栓塞性中风. 这一案例凸显了即使在接受长期IVIG治疗的低风险患者中,警的重要性.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 血管医学 血管医学
背景情况:
- 慢性炎症性脱髓化多基原蛋白神经病 (CIDP) 是一种罕见的自身免疫性疾病,影响周围神经.
- 静脉注射免疫球蛋白 (IVIG) 是一种常见的CIDP治疗方法,通常被认为是安全的.
- 长期的IVIG维持疗法通常需要用于管理CIDP症状.
研究的目的:
- 报告一种罕见的栓塞性缺血性中风病例,该病例发生在长期IVIG治疗CIDP期间.
- 强调严重不良事件的潜力,即使在耐受良好的治疗.
- 强调需要在接受维护IVIG的患者中保持持续警.
主要方法:
- 一个51岁的男性患有CIDP的病例报告.
- 详细审查患者的病史和IVIG治疗过程.
- 神经成像 (脑MRI) 来确认栓塞性心脏病发作.
- 评估传统中风风险因素和替代性栓塞源.
主要成果:
- 患者在第112次IVIG输液后立即经历了急性栓塞性缺血性中风.
- 没有发现可识别的中风或其他栓塞源的传统风险因素.
- 尽管患者多年来耐受IVIG很好,但中风发生了.
结论:
- 栓塞性中风是长期IVIG治疗CIDP的一个潜在的,尽管很少见的并发症.
- 这种风险甚至存在于年轻人身上,否则风险较低的个体.
- 医疗保健提供者应保持对维护IVIG患者神经事件的警.
相关概念视频
Venous Thrombosis III: Interprofessional Care
400
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
400
Myocarditis III: Medical Management
251
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
251
Venous Thrombosis IV: Nursing Management
288
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
288
Myocarditis IV: Nursing Management
286
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
286
Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.1K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.1K
Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K


